JPRN-UMIN000048555尚未招募2 期
eoadjuvant Gemcitabine+nab-Paclitaxel for resectable and borderline resectable pancreatic cancer-feasibility study for the elderly - GANAC-PE study
Hyogo Prefectural Awaji Medical Center0 个研究点目标入组 50 人开始时间: 2022年8月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with active multiple cancer lesions 2) Patients with any history of serious allergic reaction 3) Patients with serious comorbidity (Infectious, respiratory, cardiac, kidney and liver diseases) 4) Patients who are judged as inappropriate research subjects
研究者
相似试验
已完成
不适用
eoadjuvant nab-paclitaxel plus gemcitabine therapy for resectable pancreatic cancer; A phase II multicenter trialResectable pancreatic cancerJPRN-UMIN000031822Hokkaido Pancreatic Cancer Study Group (HOPS)50
进行中（未招募）
2 期
eoadjuvant nab-paclitaxel plus gemcitabine therapy for resectable pancreatic cancer; A phase II multicenter trialJPRN-jRCT1011180032Hirano Satoshi50
已完成
不适用
Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for borderline resectable pancreatic cancer: Phase I studypancreatic cancerJPRN-UMIN000012456Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases42
招募中
2 期
Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable pancreatic cancer: Phase II studypancreatic cancerJPRN-UMIN000018803Department of Gastroenterological Surgery, Osaka Medical Center for Cancer & Cardiovascular Diseases50
招募中
2 期
Preoperative gemcitabine plus nab-paclitaxel, concurrent 3D conformal radiation therapy for resectable and borderline resectable pancreatic cancer: Phase II studypancreatic cancerJPRN-UMIN000027758Department of Gastroenterological Surgery, Osaka International Cancer Institute50